SLC30A10 is a cell surface-localized manganese efflux transporter, And parkinsonism-causing mutations block its intracellular trafficking and efflux activity

Dinorah Leyva-Illades, Pan Chen, Charles E. Zogzas, Steven Hutchens, Jonathan M. Mercado, Caleb D. Swaim, Richard A. Morrisett, Aaron B. Bowman, Michael Aschner, Somshuvra Mukhopadhyay

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Manganese (Mn) is an essential metal, but elevated cellular levels are toxic and may lead to the development of an irreversible parkinsonian-like syndrome that has no treatment. Mn-induced parkinsonism generally occurs as a result of exposure to elevated Mn levels in occupational or environmental settings. Additionally, patients with compromised liver function attributable to diseases, such as cirrhosis, fail to excrete Mn and may develop Mn-induced parkinsonism in the absence of exposure to elevated Mn. Recently, a new form of familial parkinsonism was reported to occur as a result of mutations in SLC30A10. The cellular function of SLC30A10 and the mechanisms by which mutations in this protein cause parkinsonism are unclear. Here, using a combination of mechanistic and functional studies in cell culture, Caenorhabditis elegans, and primary midbrain neurons, we show that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and protects against Mn-induced toxicity. Importantly, mutations in SLC30A10 that cause familial parkinsonism blocked the ability of the transporter to traffic to the cell surface and to mediate Mn efflux. Although expression of disease-causing SLC30A10 mutations were not deleterious by themselves, neurons and worms expressing these mutants exhibited enhanced sensitivity to Mn toxicity. Our results provide novel insights into the mechanisms involved in the onset of a familial form of parkinsonism and highlight the possibility of using enhanced Mn efflux as a therapeutic strategy for the potential management of Mn-induced parkinsonism, including that occurring as a result of mutations in SLC30A10.

Original languageEnglish (US)
Pages (from-to)14079-14095
Number of pages17
JournalJournal of Neuroscience
Volume34
Issue number42
DOIs
StatePublished - Oct 15 2014

Fingerprint

Parkinsonian Disorders
Manganese
Mutation
Neurons
Poisons
Caenorhabditis elegans
Mesencephalon
Fibrosis
Cell Culture Techniques
Metals

Keywords

  • Efflux
  • GPP130
  • Manganese
  • Parkinsonism
  • SLC30A10
  • Trafficking

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

SLC30A10 is a cell surface-localized manganese efflux transporter, And parkinsonism-causing mutations block its intracellular trafficking and efflux activity. / Leyva-Illades, Dinorah; Chen, Pan; Zogzas, Charles E.; Hutchens, Steven; Mercado, Jonathan M.; Swaim, Caleb D.; Morrisett, Richard A.; Bowman, Aaron B.; Aschner, Michael; Mukhopadhyay, Somshuvra.

In: Journal of Neuroscience, Vol. 34, No. 42, 15.10.2014, p. 14079-14095.

Research output: Contribution to journalArticle

Leyva-Illades, Dinorah ; Chen, Pan ; Zogzas, Charles E. ; Hutchens, Steven ; Mercado, Jonathan M. ; Swaim, Caleb D. ; Morrisett, Richard A. ; Bowman, Aaron B. ; Aschner, Michael ; Mukhopadhyay, Somshuvra. / SLC30A10 is a cell surface-localized manganese efflux transporter, And parkinsonism-causing mutations block its intracellular trafficking and efflux activity. In: Journal of Neuroscience. 2014 ; Vol. 34, No. 42. pp. 14079-14095.
@article{d302d6f1b3024daaa3d2a0664a3da113,
title = "SLC30A10 is a cell surface-localized manganese efflux transporter, And parkinsonism-causing mutations block its intracellular trafficking and efflux activity",
abstract = "Manganese (Mn) is an essential metal, but elevated cellular levels are toxic and may lead to the development of an irreversible parkinsonian-like syndrome that has no treatment. Mn-induced parkinsonism generally occurs as a result of exposure to elevated Mn levels in occupational or environmental settings. Additionally, patients with compromised liver function attributable to diseases, such as cirrhosis, fail to excrete Mn and may develop Mn-induced parkinsonism in the absence of exposure to elevated Mn. Recently, a new form of familial parkinsonism was reported to occur as a result of mutations in SLC30A10. The cellular function of SLC30A10 and the mechanisms by which mutations in this protein cause parkinsonism are unclear. Here, using a combination of mechanistic and functional studies in cell culture, Caenorhabditis elegans, and primary midbrain neurons, we show that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and protects against Mn-induced toxicity. Importantly, mutations in SLC30A10 that cause familial parkinsonism blocked the ability of the transporter to traffic to the cell surface and to mediate Mn efflux. Although expression of disease-causing SLC30A10 mutations were not deleterious by themselves, neurons and worms expressing these mutants exhibited enhanced sensitivity to Mn toxicity. Our results provide novel insights into the mechanisms involved in the onset of a familial form of parkinsonism and highlight the possibility of using enhanced Mn efflux as a therapeutic strategy for the potential management of Mn-induced parkinsonism, including that occurring as a result of mutations in SLC30A10.",
keywords = "Efflux, GPP130, Manganese, Parkinsonism, SLC30A10, Trafficking",
author = "Dinorah Leyva-Illades and Pan Chen and Zogzas, {Charles E.} and Steven Hutchens and Mercado, {Jonathan M.} and Swaim, {Caleb D.} and Morrisett, {Richard A.} and Bowman, {Aaron B.} and Michael Aschner and Somshuvra Mukhopadhyay",
year = "2014",
month = "10",
day = "15",
doi = "10.1523/JNEUROSCI.2329-14.2014",
language = "English (US)",
volume = "34",
pages = "14079--14095",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "42",

}

TY - JOUR

T1 - SLC30A10 is a cell surface-localized manganese efflux transporter, And parkinsonism-causing mutations block its intracellular trafficking and efflux activity

AU - Leyva-Illades, Dinorah

AU - Chen, Pan

AU - Zogzas, Charles E.

AU - Hutchens, Steven

AU - Mercado, Jonathan M.

AU - Swaim, Caleb D.

AU - Morrisett, Richard A.

AU - Bowman, Aaron B.

AU - Aschner, Michael

AU - Mukhopadhyay, Somshuvra

PY - 2014/10/15

Y1 - 2014/10/15

N2 - Manganese (Mn) is an essential metal, but elevated cellular levels are toxic and may lead to the development of an irreversible parkinsonian-like syndrome that has no treatment. Mn-induced parkinsonism generally occurs as a result of exposure to elevated Mn levels in occupational or environmental settings. Additionally, patients with compromised liver function attributable to diseases, such as cirrhosis, fail to excrete Mn and may develop Mn-induced parkinsonism in the absence of exposure to elevated Mn. Recently, a new form of familial parkinsonism was reported to occur as a result of mutations in SLC30A10. The cellular function of SLC30A10 and the mechanisms by which mutations in this protein cause parkinsonism are unclear. Here, using a combination of mechanistic and functional studies in cell culture, Caenorhabditis elegans, and primary midbrain neurons, we show that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and protects against Mn-induced toxicity. Importantly, mutations in SLC30A10 that cause familial parkinsonism blocked the ability of the transporter to traffic to the cell surface and to mediate Mn efflux. Although expression of disease-causing SLC30A10 mutations were not deleterious by themselves, neurons and worms expressing these mutants exhibited enhanced sensitivity to Mn toxicity. Our results provide novel insights into the mechanisms involved in the onset of a familial form of parkinsonism and highlight the possibility of using enhanced Mn efflux as a therapeutic strategy for the potential management of Mn-induced parkinsonism, including that occurring as a result of mutations in SLC30A10.

AB - Manganese (Mn) is an essential metal, but elevated cellular levels are toxic and may lead to the development of an irreversible parkinsonian-like syndrome that has no treatment. Mn-induced parkinsonism generally occurs as a result of exposure to elevated Mn levels in occupational or environmental settings. Additionally, patients with compromised liver function attributable to diseases, such as cirrhosis, fail to excrete Mn and may develop Mn-induced parkinsonism in the absence of exposure to elevated Mn. Recently, a new form of familial parkinsonism was reported to occur as a result of mutations in SLC30A10. The cellular function of SLC30A10 and the mechanisms by which mutations in this protein cause parkinsonism are unclear. Here, using a combination of mechanistic and functional studies in cell culture, Caenorhabditis elegans, and primary midbrain neurons, we show that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and protects against Mn-induced toxicity. Importantly, mutations in SLC30A10 that cause familial parkinsonism blocked the ability of the transporter to traffic to the cell surface and to mediate Mn efflux. Although expression of disease-causing SLC30A10 mutations were not deleterious by themselves, neurons and worms expressing these mutants exhibited enhanced sensitivity to Mn toxicity. Our results provide novel insights into the mechanisms involved in the onset of a familial form of parkinsonism and highlight the possibility of using enhanced Mn efflux as a therapeutic strategy for the potential management of Mn-induced parkinsonism, including that occurring as a result of mutations in SLC30A10.

KW - Efflux

KW - GPP130

KW - Manganese

KW - Parkinsonism

KW - SLC30A10

KW - Trafficking

UR - http://www.scopus.com/inward/record.url?scp=84907967528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907967528&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2329-14.2014

DO - 10.1523/JNEUROSCI.2329-14.2014

M3 - Article

C2 - 25319704

AN - SCOPUS:84907967528

VL - 34

SP - 14079

EP - 14095

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 42

ER -